Caroline Young - 01 Dec 2022 Form 4 Insider Report for CUMBERLAND PHARMACEUTICALS INC (CPIX)

Role
Director
Signature
Caroline Young by /s/ John Hamm as attorney-in-fact
Issuer symbol
CPIX
Transactions as of
01 Dec 2022
Net transactions value
+$849
Form type
4
Filing time
23 Dec 2022, 16:13:02 UTC
Previous filing
23 Dec 2022
Next filing
27 Mar 2023
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CPIX Common Stock Purchase $46.6 +20 +0.1% $2.33 19,228 01 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $46.2 +20 +0.1% $2.31 19,248 02 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $43.8 +20 +0.1% $2.19 19,268 05 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $43.8 +20 +0.1% $2.19 19,288 06 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $43.6 +20 +0.1% $2.18 19,308 07 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $43.8 +20 +0.1% $2.19 19,328 08 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $43 +20 +0.1% $2.15 19,348 09 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $42.8 +20 +0.1% $2.14 19,368 12 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $43.6 +20 +0.1% $2.18 19,388 13 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $44.2 +20 +0.1% $2.21 19,408 14 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $44.8 +20 +0.1% $2.24 19,428 15 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $44.4 +20 +0.1% $2.22 19,448 16 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $66.3 +30 +0.15% $2.21 19,478 19 Dec 2022 Direct F1
transaction CPIX Common Stock Purchase $252 +109 +0.56% $2.31 19,587 20 Dec 2022 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The purchases reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person during March 2022.